Drug Information

Drug General Information
Drug ID
D09FOQ
Former ID
DIB018941
Drug Name
bantag-1
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530652]
Structure
Download
2D MOL
Formula
C49H82N8O7+2
InChI
InChI=1S/C49H80N8O7/c1-33(2)23-40(45(60)51-29-36-21-16-22-37(24-36)31-57(7,8)9)53-44(59)28-43(58)39(25-34-17-12-10-13-18-34)54-46(61)42(27-38-30-50-32-52-38)56(6)47(62)41(26-35-19-14-11-15-20-35)55-48(63)64-49(3,4)5/h11,14,19,21,24,30,32-34,39-43,46,54,58,61H,10,12-13,15-18,20,22-23,25-29,31H2,1-9H3,(H3-,50,51,52,53,55,59,60,63)/p+2/t39-,40-,41-,42-,43-,46?/m0/s1
InChIKey
DAWSYEXBFLQUER-SLMIJXFKSA-P
PubChem Compound ID
73755180
PubChem Substance ID
178102797
Target and Pathway
Target(s) Bombesin receptor Target Info Antagonist [532441]
Gastrin-releasing peptide receptor Target Info Antagonist [532441]
KEGG Pathway Neuroactive ligand-receptor interactionhsa04020:Calcium signaling pathway
Neuroactive ligand-receptor interaction
Reactome Peptide ligand-binding receptors
G alpha (q) signalling eventsR-HSA-375276:Peptide ligand-binding receptors
G alpha (q) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Peptide GPCRsWP455:GPCRs, Class A Rhodopsin-like
Peptide GPCRs
GPCRs, Other
References
Ref 530652Regulation of energy homeostasis by bombesin receptor subtype-3: selective receptor agonists for the treatment of obesity. Cell Metab. 2010 Feb 3;11(2):101-12.
Ref 532441Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors. J Pharmacol Exp Ther. 2013 Oct;347(1):100-16.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.